Navigation Links
deCODE genetics Announces First Quarter 2009 Financial Results
Date:5/11/2009

REYKJAVIK, Iceland, May 11 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced its consolidated financial results for the quarter ended March 31, 2009. A conference call to discuss these results and recent developments in the company's business will be webcast live tomorrow, Tuesday, May 12, at 8:00am Eastern Daylight Time/12 noon GMT/1pm British Summer Time (details below).

Net loss for the quarter ended March 31, 2009 was $12.6 million, compared to $26.7 million for the first quarter 2008. Basic and diluted net loss per share was $0.21 for the first quarter 2009, compared to $0.44 for first quarter last year. At March 31, 2009, the company had approximately 61.8 million shares outstanding.

Revenue for the first quarter 2009 was $8.9 million, versus $15.0 million for the first quarter last year. This decline is due principally to lower contract service revenues. At March 31, 2009, the company had $12.7 million in deferred revenue, which will be recognized over future reporting periods.

Research and development expense for proprietary programs was $4.2 million for the first quarter of this year, compared to $12.7 million for the same period last year. This reflects the company's current focus on applying its established capabilities in human genetics to drive its diagnostics and deCODEme businesses, and the curtailment of investment in clinical trials for its therapeutics programs reflected in the 2008 period. Selling, general and administrative expenses for the first quarter 2009 were $4.9 million, compared to $7.2 million for the first quarter 2008.

At March 31, 2009, the company had cash and cash equivalents of $6.1 million, compared to $3.7 million at December 31, 2008. In early 2009 the company sold its auction rate securities (ARS) for approximately $11.0 mil
'/>"/>

SOURCE deCODE genetics Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results
2. Nasdaq Stays Suspension of Trading in deCODE Stock
3. deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
4. deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes
5. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2008 Financial Results
6. Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
7. deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market
8. deCODE Discovers First Genetic Variant Conferring Increased Risk of Essential Tremor
9. deCODE Sells Auction Rate Securities
10. Introducing deCODEme Cardio(TM) and deCODEme Cancer(TM)
11. deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014  Next month, executives from clinical trial marketing ... events beginning with Patient-Centered Clinical Trials 2014 , to ... Boston , September 4-5. Patient recruitment experts Bonnie ... Fleishman will share insights on the benefits of employing ... tactics – from media to mobile apps – can be ...
(Date:8/28/2014)... , Aug. 28, 2014  Armetheon, Inc. ... developing novel mid- to late-stage cardiovascular drug candidates, ... in its first round of financing. The Series ... and Hercules Bioventures with participation from investors that ... pharmaceutical executive, Dr. Larry Hsu , the ...
(Date:8/28/2014)... Vt. (PRWEB) August 28, 2014 ... testing around the world is available from Strategic ... diagnostics companies. “ Industrial Microbiology Market Review, Fourth ... Industrial Market ” (IMMR—4) tracks and compares microbiology ... in North America, Europe and Asia, and forecasts ...
(Date:8/28/2014)... 2014 Supplementing their complete line ... for Eppendorf Safe Lock Centrifuge Tubes . ... highest quality tubes at an affordable price. Eppendorf ... doing chemical, medical, pharmaceutical, and life science research ... regularly able to afford Eppendorf products. , Eppendorf ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3
... ShapeGrabber and Nikon,Instruments Inc. today announced ... a,sales distribution channel in the United States ... inspection systems. This arrangement will,increase ShapeGrabber,s current ... Nikon to provide customers with,additional non-contact solutions ...
... Mr. Stewart brings critical experience in strategic and operational leadership ... ... opportunities, COLUMBIA, Md., April 8, 2008 ... of the Company. Cylex is a,global life sciences company that develops ...
... Fla., April 8, 2008 GeoPharma, Inc.,(Nasdaq: ... today at the,EdgeWater Research Partners Spring Conference being ... 2:25 MT., "We are thoroughly pleased to ... President David Lavigne. "GeoPharma has a,unique story with ...
Cached Biology Technology:ShapeGrabber and Nikon Instruments Inc. Announce Distribution Agreement 2Cylex Announces Brad L. Stewart as President of the Company 2GeoPharma to Present at EdgeWater Research Partners Conference 2
(Date:8/28/2014)... 2014 Dyslexia, the most commonly diagnosed learning ... reading disability that occurs when the regions of ... normally. , The use of non-invasive functional neuroimaging ... disrupted in dyslexia. However, most prior work has ... regions, leaving a gap in our understanding of ...
(Date:8/28/2014)... northern California, and Alaska totaled 515 million board feet ... increase of more than 10 percent compared to the ... Northwest Research Station reported today. During this same period, ... 247 million board feet. , The total value of ... to $390 million in the same quarter, while the ...
(Date:8/27/2014)... Aug. 27, 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) ... underwritten public offering of units of common stock and ... gross proceeds of $20 million, prior to deducting underwriting ... Company.  The shares and warrants are immediately separable and ... sold in the offering consists of 2,000 shares of ...
Breaking Biology News(10 mins):Dyslexic readers have disrupted network connections in the brain 2West coast log exports up, lumber exports down in second quarter of 2014 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3
... to company, JERICHO, N.Y. and GUANGZHOU, China, ... SKI Engineering, jointly announced,that they have formed a ... and manufacturing capabilities., "I,m extremely excited about ... Basile, CEO of bioMETRX. "The former Sequiam East,s,engineering ...
... First identified in 1899, y-larvae have been one of ... one has ever found an adult of these puzzling ... leading generations of marine zoologists to wonder just what ... in BioMed Centrals open access journal, BMC Biology, reports ...
... the missing flu virus. When the flu isnt making people ... on Earth, it reappears in the appropriate season and starts ... Does it hibernate, lying dormant in a few people and ... the Northern hemisphere to the Southern hemisphere and back, following ...
Cached Biology News:bioMETRX Expands Engineering and Manufacturing Capabilities 2bioMETRX Expands Engineering and Manufacturing Capabilities 3Clue to mystery crustacean in parasite form 2Tracking influenza's every movement 2
... Forma Refrigerated Console Orbital Shakers combine ... ergonomics, unequalled programming power. The ... allowing the unit to run with ... HEPA filtration system reduces contamination. ...
... Transcriptase (RT) is an improved version of ... a DNA polymerase that synthesizes a complementary ... an RNA:DNA hybrid. This enzyme is genetically ... rather than a deletion in the RNase ...
... The Cellject Uno Electroporator is a ... producing optimum efficiencies in bacterial and ... selects one of two voltages and ... four mm cuvettes. On pressing the ...
... CGH Genomic Labeling Systems are a high-performance ... genomic DNA samples for array-based Comparative Genomic ... direct labeling formats, the BioPrime Plus Array ... solution to your genomic labeling needs. ...
Biology Products: